SGRY Neutral Sentiment
Information Relating to Part II. Item 14. - Other Expenses of Issuance and Distribution The expenses in connection with the offer and sale of common stock of Surgery Partners, Inc., registered pursuant to the Registratio
Monday, December 18, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Surgery Partners, Inc. has disclosed details regarding the expenses associated with the offer and sale of its common stock, as part of its Registration Statement filed with the SEC. The estimated total expenses are approximately $739,485.95, comprising various fees including legal, accounting, and printing expenses. The announcement specifically outlines costs related to the SEC registration fee, among others. This information is crucial for potential investors to understand the financial implications of the stock issuance.
Full Press Release Details
Information Relating to Part II.
Item 14. - Other Expenses of Issuance and Distribution
The expenses in connection
with the offer and sale of common stock of Surgery Partners, Inc., registered pursuant to the Registration Statement on Form S-3ASR
(Registration No. 333-252399) filed on January 25, 2021, other than underwriting discounts and commissions, are set forth in
the following table. All amounts are estimated except the Securities and Exchange Commission registration fee.
| SEC Registration Fee | | $ | 39,485.95 | |
| Legal fees and expenses | | | 500,000 | |
| Accounting fees and expenses | | | 150,000 | |
| Blue Sky fees and expenses | | | 10,000 | |
| Printing expenses | | | 20,000 | |
| Miscellaneous | | | 20,000 | |
| Total | | $ | 739,485.95 | |